|
Market Closed -
NYSE
16:00:02 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 18.54 USD | -4.24% |
|
-16.18% | -22.20% |
| 10-22 | Arcus Biosciences Prices $250 Million Common Stock Offering; Shares Down Pre-Bell | MT |
| 10-21 | Wedbush Adjusts Price Target on Arcus Biosciences to $49 From $43, Keeps Outperform Rating | MT |
| Market Cap | 2.36B 2.11B 1.95B 1.76B 3.3B 224B 3.36B 23.44B 9.28B 117B 8.86B 8.67B 370B | P/E 2026 * |
-5.23x | P/E 2027 * | -5.57x |
|---|---|---|---|---|---|
| Enterprise Value | 1.92B 1.71B 1.58B 1.44B 2.69B 182B 2.73B 19.06B 7.55B 95.5B 7.21B 7.05B 301B | EV / Sales 2026 * |
26.3x | EV / Sales 2027 * | 40x |
| Free-Float |
74.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| RCUS | Delayed | |
CBOE
| RCUS | Real-time |
Last Transcript: Arcus Biosciences, Inc.
| 1 day | -4.24% | ||
| 1 week | -16.18% | ||
| Current month | -28.22% | ||
| 1 month | -29.75% | ||
| 3 months | -37.64% | ||
| 6 months | -26.22% | ||
| Current year | -22.20% |
| 1 week | 17.43 |  | 24.7 |
| 1 month | 17.43 | | 26.35 |
| Current year | 17.43 | | 31.74 |
| 1 year | 17.43 | | 31.74 |
| 3 years | 6.5 | | 31.74 |
| 5 years | 6.5 | | 49.1 |
| 10 years | 6.3 | | 49.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Juan Jaen
PSD | President | 68 | 2015-04-30 |
Terry Rosen
CEO | Chief Executive Officer | 67 | 2015-04-30 |
Robert Goeltz
DFI | Director of Finance/CFO | 53 | 2020-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Terry Rosen
CHM | Chairman | 67 | 2017-11-30 |
Kathryn Falberg
BRD | Director/Board Member | 65 | 2017-09-17 |
Yasunori Kaneko
BRD | Director/Board Member | 72 | 2015-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/21/26 | Exercice | Controller/Auditor | 8,481 | 0.0067% | ||
| 7/10/26 | Sell | Founder | -20,067 | 0.0160% | ||
| 6/11/26 | Free | Director | 22,600 | 0.0180% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.24% | -16.18% | +10.49% | +14.59% | 2.36B | |
| +2.41% | +0.29% | +42.02% | +71.57% | 64.69B | |
| -0.15% | +7.50% | +11.01% | +73.48% | 54.78B | |
| +0.57% | +4.60% | +10.07% | +92.86% | 53.49B | |
| +0.37% | +4.67% | +27.03% | +52.07% | 45.98B | |
| -1.21% | +2.32% | +21.80% | +123.81% | 42.94B | |
| -0.37% | +5.07% | +249.91% | +918.74% | 40.08B | |
| +0.05% | +0.21% | +18.26% | +58.53% | 33.52B | |
| -0.38% | +5.68% | +36.43% | +27.54% | 23.67B | |
| +1.19% | -4.98% | +29.01% | -0.65% | 23.97B | |
| Average | -0.18% | +0.39% | +45.60% | +143.25% | 38.55B | |
| Weighted average by Cap. | +0.36% | +2.51% | +47.34% | +157.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 73.15M 65.32M 60.34M 54.68M 102M 6.94B 104M 726M 287M 3.64B 275M 269M 11.47B | 56.52M 50.47M 46.62M 42.25M 79.05M 5.36B 80.35M 561M 222M 2.81B 212M 208M 8.86B |
| Net income | -449M -401M -370M -336M -628M -42.61B -638M -4.46B -1.76B -22.33B -1.68B -1.65B -70.39B | -413M -369M -341M -309M -578M -39.22B -587M -4.1B -1.62B -20.55B -1.55B -1.52B -64.79B |
| Net Debt | -441M -393M -364M -329M -616M -41.83B -627M -4.37B -1.73B -21.92B -1.65B -1.62B -69.1B | -102M -91.23M -84.28M -76.37M -143M -9.7B -145M -1.01B -402M -5.08B -383M -375M -16.02B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | US$18.54 | -4.24% | 5,925,216 |
| 26-10-22 | US$19.36 | +1.36% | 8,370,962 |
| 26-10-21 | US$19.10 | -19.58% | 4,654,346 |
| 26-10-20 | US$23.75 | +7.27% | 6,242,268 |
| 26-10-19 | US$22.14 | +0.09% | 3,516,696 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RCUS Stock
Select your edition
All financial news and data tailored to specific country editions
